ANODYNE NANOTECH
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery. The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.
ANODYNE NANOTECH
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.theheropatch.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.2 M USD
Technology used in webpage:
Euro Google Google Cloud
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Relativity Healthcare Partners
Relativity Healthcare Partners investment in Seed Round - Anodyne Nanotech
Big Pi Ventures
Big Pi Ventures investment in Seed Round - Anodyne Nanotech
Velocity Partners
Velocity Partners investment in Seed Round - Anodyne Nanotech
Bantam Group
Bantam Group investment in Seed Round - Anodyne Nanotech
Velocity Partners
Velocity Partners investment in Seed Round - Anodyne Nanotech
Official Site Inspections
http://www.theheropatch.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Anodyne Nanotech"
About Us | Anodyne Nanotech - theheropatch.com
At Anodyne Nanotech, we believe that breakthrough medicines require unique delivery systems to reach their full potential and provide the desired clinical outcomes.See details»
Home | Anodyne Nanotech
Anodyne is a clinical-stage biotech company simplifying chronic care for every stakeholder. We enable the transdermal delivery of. multi-milligram doses and complex formulations of existing therapies and emerging large molecules.See details»
Anodyne Nanotech - Crunchbase Company Profile
Contact Email [email protected] Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high โฆSee details»
Anodyne Nanotech, Inc - LinkedIn
Anodyne Nanotech, Inc | 1,571 followers on LinkedIn. Simplifying Chronic Care | Anodyne is a venture-backed, clinical-stage biotech company focused on simplifying chronic care for all stakeholders.See details»
Anodyne Nanotech - Overview, News & Similar companies
Apr 8, 2021 Who is Anodyne Nanotech. Based in Boston, MA, Anodyne is a biotech company developing differentiated, transdermal forms of high-value drugs. The companys patent โฆSee details»
Anodyne Nanotech - Work in biotech
Anodyne Nanotech is leveraging the power of nanotechnology by pioneering innovative transdermal drug delivery solutions. Their mission is to redefine drug delivery by overcoming โฆSee details»
Anodyne Nanotech - Velocity.Partners
Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The companyโs patent-pending, porous microneedle technology provides the first practical and cost-effective platform, โฆSee details»
Anodyne Nanotech - Craft
Anodyne Nanotech is a biotech company that develops differentiated and transdermal forms of drugs. Its porous microneedle technology provides a practical platform called Hero Patch for โฆSee details»
Anodyne Nanotech, Inc. (Anodyne Nanotech, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธ โฆ
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for โฆSee details»
Boston Biotech, Anodyne Nanotech Advances the Hero Patch โฆ
Apr 8, 2021 ๏ปฟAnodyne Nanotech, Inc., a Boston-based biotechnology company developing differentiated, transdermal forms of high-value drugs, announced today that it has raised โฆSee details»
Anodyne Nanotech Achieves Breakthrough in Transdermal
Dec 19, 2024 The company is advancing multiple assets into clinical development for conditions such as diabetes, obesity, autoimmune diseases, and oncology. For more information, visit โฆSee details»
Company Information - RocketReach
Anodyne is a venture-backed, clinical-stage biotech company focused on simplifying chronic care for all stakeholders. We specialize in the transdermal delivery of multi-milligram doses and โฆSee details»
Big Pi leads Anodyne's $2.25m fundraising
May 31, 2023 Anodyne Nanotech. Inc (www.theheropatch.com), one of our portfolio companies, based in Athens and Boston, successfully raised additional funding of $2.25ฮ, making โฆSee details»
Anodyne Nanotech - VentureRadar
"Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The companyโs patent-pending, porous microneedle technology provides โฆSee details»
JPM 2025 | Anodyne Nanotech - theheropatch.com
Anodyne will be attending the J.P. Morgan Healthcare Conference 2025, happening January 13-16 in San Francisco, California. This event brings together leaders from across the industry to โฆSee details»
theheropatch.com - Anodyne Nanotech - Theheropatch - Sur.ly
Theheropatch.com. Preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs.See details»
PODD 2024 | Anodyne Nanotech - theheropatch.com
Boston, MA โ Anodyne is pleased to present preclinical data on our once-weekly GLP-1 patch at the 14th annual Partnerships in Drug Delivery (PODD2024) Conference, held October 28-29 in โฆSee details»
Our Technology | Anodyne Nanotech - theheropatch.com
The final result is a complete delivery of the drug loaded for systemic uptake, and an array of empty microneedles that can be removed. On the left, there is a representation of the โฆSee details»
Online payment @ theheropatch.com
Online payment. Please enter any details in the notes section. Enter Amount *. Notes โขโขโขโขโขโขSee details»
Media - Anodyne Nanotech
Mar 10, 2025 Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MASee details»